Long-acting injectable cabotegravir for prep
Clinical trials for Long-acting injectable cabotegravir for prep explained in plain language.
Never miss a new study
Get alerted when new Long-acting injectable cabotegravir for prep trials appear
Sign up with your email to follow new studies for Long-acting injectable cabotegravir for prep, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can better support keep people on HIV prevention? massive malawi trial aims to find out
Prevention Recruiting nowThis large study in Malawi will test whether extra support—like better communication with providers, peer counselors, and earlier clinic hours—helps people at high risk for HIV stay on their prevention medication. It includes both daily pills and a new long-acting injectable. Nea…
Matched conditions: LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP
Sponsor: Georgetown University • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
Malawi study tracks why women stop HIV prevention
Knowledge-focused Recruiting nowThis study looks at how women in Blantyre, Malawi choose and use HIV prevention pills or injections. Researchers will follow 384 women to see why some stop taking PrEP and how tracing them can help re-engage them in care. The goal is to improve HIV prevention services for women a…
Matched conditions: LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC